Skip to main content

Palivizumab Dosage

Medically reviewed by Drugs.com. Last updated on Dec 1, 2023.

Applies to the following strengths: 100 mg; 50 mg; 100 mg/mL

Usual Pediatric Dose for Respiratory Syncytial Virus

Pediatric patients 24 months of age or less:
15 mg/kg IM once a month during RSV season (the first dose should be administered prior to commencement of the RSV season and the remaining doses should be administered monthly throughout the RSV season)

Comments:


Use: For the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in children at high risk of RSV disease. The following points should be considered when prescribing this drug:

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

Safety and efficacy have not been established in patients older than 24 months of age at the start of dosing.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:


General:

Reconstitution/Preparation:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.